Update on Acute Myeloid Leukemia (AML) Diagnosis, Treatment, Support & Research
 

Welcome to

Update on Acute Myeloid Leukemia (AML) Diagnosis, Treatment, Support & Research


January 10, 2019

Anaheim Marrriott

700 W. Convention , Anaheim, CA, 92800


Program: 6:00 pm  - 8:00 pm

Registration: 6:00pm
Dinner:  6:30pm
Program:  7:00pm to 8:00pm

Speaker

Molly Oswald, RN, MSN, AGNP-C, CCRP
University of California Los Angeles

 

Program Goal
To provide a learning opportunity for oncology nurses to expand their knowledge about treating hematology oncology patients with AML 


Continuing Education (CE) Information 

 Objectives: At the end of the program participants will be able to  :

  • Describe current and emerging treatments for acute myeloid leukemia (AML)
  • Identify diagnostic tests included in standard AML panels, and the role of cytogenetic & molecular analysis
  • Engage Patients and caregivers in clinical trials discussion, on emerging therapies for AML
  • Apply nursing strategies for optimal nursing care
  • Provide information on resources LLS support services for patients, their families and health care providers, throughout the patient's treatment

Target Audience: 
Oncology Nurses at the intermediate levels of practice and caring for the adult patient with acute myeloid leukemia

Upon completion of this program and submission of the activity evaluation, a certificate of completion will be emailed to you within 30 days.

Pre-registration for this program is required.


To register, please click on the REGISTER tab above.